Placement Announced
BridgeBio Pharma placement
US$1bn raised
Announced 1 Jul 2026 · NASDAQ: BBIO
Advisers
Lead managers
Not disclosed
Investor
- Financial adviser
- Legal adviser
- Issuer
- BridgeBio Pharma
- Issuer based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Pharma
Similar deals
- Latigo Biotherapeutics IPO Aug 2026 · US$346m · Biotech
- Hemab Therapeutics Holdings IPO Apr 2026 · US$302m · Biotech
- Avalyn Pharma IPO Apr 2026 · US$300m · Biotech
- Mentari Therapeutics placement May 2026 · US$290m · Biotech
- Veradermics IPO Feb 2026 · US$256m · Dermatology



